Freshness note: This analysis was last updated 26 days ago. Fast-moving policy claims can change quickly, so check for newer official updates before relying on this verdict.
“A specific form of brain training conducted in the 1990s reduced dementia risk for people over the following 20 years”
Summary
The ACTIVE study, which began in 1998, tested three forms of cognitive training on adults aged 65 and older. A 2025 analysis published in Alzheimer's & Dementia found that participants who received speed-of-processing training showed a 29% reduction in dementia risk over 20 years compared to the control group. The other two training types (memory and reasoning) did not show significant dementia risk reduction.
Primary Sources
Official description of the ACTIVE trial, which began in 1998 with over 2,800 participants testing cognitive training interventions
2025 published analysis showing 29% reduction in dementia risk for speed-of-processing training group over 20-year follow-up
News coverage reporting on the 20-year ACTIVE study results showing dementia risk reduction from speed-of-processing training
Evidence Supporting the Claim
- The ACTIVE study enrolled 2,802 adults aged 65 and older starting in 1998, testing three types of cognitive training: memory, reasoning, and speed-of-processing
- Participants in the speed-of-processing training group showed a 29% lower risk of developing dementia over 20 years compared to the control group that received no training
- The study conducted follow-up assessments over two decades, tracking dementia diagnoses through 2018
- The speed-of-processing training involved computerized exercises designed to improve visual attention and processing speed
Evidence Against / Context
- The other two forms of cognitive training tested in the ACTIVE study (memory training and reasoning training) did not show statistically significant reductions in dementia risk
- Only one specific type of brain training demonstrated the protective effect, not brain training generally
- The study began in 1998, not strictly the early 1990s, though it is commonly characterized as a 1990s-era study
- The speed-of-processing training group received booster sessions in addition to initial training, which may have contributed to outcomes
Timeline
ACTIVE study enrollment began, recruiting 2,802 adults aged 65 and older at six research sites
Initial cognitive training interventions administered to randomized groups
Ten-year follow-up results published showing cognitive benefits but limited functional improvements
Twenty-year analysis published in Alzheimer's & Dementia showing 29% dementia risk reduction for speed-of-processing training group
What This Means
Structured interpretation — not opinion
Key takeaway 1
The claim is supported by peer-reviewed research from a long-term randomized controlled trial funded by the National Institute on Aging
Key takeaway 2
The protective effect was specific to speed-of-processing training, which involves timed visual exercises, and did not extend to other cognitive training approaches tested
Key takeaway 3
A 29% risk reduction represents a meaningful but not absolute protection against dementia, and the training required both initial sessions and periodic booster sessions
Key takeaway 4
These findings suggest that specific, targeted cognitive interventions earlier in life may have long-term neurological benefits, though replication studies would strengthen the evidence
Related Claims in health
“The FDA was changing leucovorin's label because it could help 'hundreds of thousands' of children with autism”
FDA Commissioner Marty Makary announced in September 2025 that the agency would change leucovorin's label to reflect potential benefits for some children with autism and cerebral folate deficiency. However, the FDA later clarified the label change applied to a rare subset of patients with a specific metabolic condition, not hundreds of thousands of children, and the agency disputed characterizations that overstated the scope of the change.
“The Trump administration enacted a 6-month moratorium on Minnesota Medicaid payments”
On February 27, 2026, the Trump administration implemented a six-month moratorium on federal Medicaid payments to Minnesota through the Centers for Medicare and Medicaid Services. The action was taken in response to Minnesota's policies regarding undocumented immigrants' access to state healthcare programs, which federal officials characterized as violations of federal law.
“90% of health care spending treats chronic disease”
The claim that 90% of healthcare spending treats chronic disease is an overstatement of the actual figures. Federal health agencies report that chronic diseases account for approximately 75-90% of healthcare spending, with the most commonly cited figure from the Centers for Disease Control and Prevention being 90% of the nation's $4.5 trillion in annual healthcare expenditures, though this appears to include broadly defined chronic conditions and may represent an upper-bound estimate.